Was it the 400% eps growth q/q, the 68% y/y revenue growth, the 38% q/q revenue growth, the q4 2012 not losing a dime that confused you. Or was it the 197 million in cash and little/no debt that confused you. Maybe it was the 1.2 billion in acquisitions in the past 18 months? Maybe it is the soon to be released 4k score PC test, or the two in house, and one licensed phase 3 products, the later granting Opk 100 m one time payment plus royalties. Yes grasping a bio mutual fund takes work, but you got time to figure it out.